PHASE II STUDY OF AMRUBICIN (AMR) COMBINED WITH CARBOPLATIN (CBDCA) FOR ELDERLY PATIENTS WITH SMALL CELL LUNG CANCER (SCLC). (NORTH JAPAN LUNG CANCER GROUP 0405)

被引：0
|
作者：
Nakamura, A. [1 ]
Sugawara, S. [2 ]
Harada, M. [3 ]
Usui, K. [4 ]
Suzuki, T. [5 ]
Yokouchi, H. [6 ]
Maemondo, M. [7 ]
Nukiwa, T. [8 ]
Inoue, A. [1 ]
机构：
[1] Tohoku Univ Hosp, Sendai, Miyagi, Japan
[2] Sendai Kosei Hosp, Dept Resp Med, Sendai, Miyagi, Japan
[3] Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan
[4] Kanto Med Ctr NTT EC, Dept Resp Med, Tokyo, Japan
[5] Isawa Hosp, Dept Resp Med, Oshu, Japan
[6] Iwamizawa Rosai Hosp, Dept Resp Med, Iwamizawa, Japan
[7] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi 9811293, Japan
[8] Tohoku Univ, Dept Resp Oncol & Mol Med, Inst Dev Aging & Cancer, Sendai, Miyagi 980, Japan
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：117 / 118
页数：2
相关论文
共 50 条
  • [21] A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC).
    Nogami, N.
    Kiura, K.
    Takigawa, N.
    Harita, S.
    Chikamori, K.
    Shibayama, T.
    Tabata, M.
    Hotta, K.
    Shinkai, T.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Survival improvement in patients (pts) with small cell lung cancer (SCLC): A historical comparison before and after amrubicin (AMR) approval in Japan
    Niho, S.
    Kubota, K.
    Yoh, K.
    Goto, K.
    Ohmatsu, H.
    Ohe, Y.
    Nishiwaki, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER
    Kinoshita, Akitoshi
    Tomonaga, Nanae
    Saijo, Tomoyuki
    Ikeda, Takaya
    Fukuda, Minoru
    Nakamura, Yoichi
    Senju, Hiroaki
    Nakano, Hirofumi
    Kitazaki, Takeshi
    Ogawara, Daiki
    Taniguchi, Hirokazu
    Motoshima, Kohei
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Shimada, Midori
    Nagashima, Seiji
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    RESPIROLOGY, 2014, 19 : 155 - 155
  • [24] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
    Takaya Ikeda
    Minoru Fukuda
    Yoichi Nakamura
    Akitoshi Kinoshita
    Hiroaki Senju
    Hirofumi Nakano
    Takeshi Kitazaki
    Daiki Ogawara
    Hirokazu Taniguchi
    Kohei Motoshima
    Hiroyuki Yamaguchi
    Katsumi Nakatomi
    Midori Shimada
    Seiji Nagashima
    Kazuhiro Tsukamoto
    Shigeru Kohno
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 497 - 502
  • [25] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
    Ikeda, Takaya
    Fukuda, Minoru
    Nakamura, Yoichi
    Kinoshita, Akitoshi
    Senju, Hiroaki
    Nakano, Hirofumi
    Kitazaki, Takeshi
    Ogawara, Daiki
    Taniguchi, Hirokazu
    Motoshima, Kohei
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Shimada, Midori
    Nagashima, Seiji
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 497 - 502
  • [26] A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER
    Ikeda, Takaya
    Taniguchi, Hirokazu
    Soda, Hiroshi
    Fukuda, Minoru
    Kinoshita, Akihito
    Fukuda, Masaaki
    Soejima, Yoshifumi
    Ogawara, Daiki
    Nakamura, Yoichi
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1157 - S1157
  • [27] A combination chemotherapy of carboplatin and irinotecan in elderly patients with small cell lung cancer (SCLC).
    Okamoto, H
    Kudoh, H
    Nagatomo, A
    Kunikane, H
    Watanabe, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 669S - 669S
  • [28] Elderly (>=75) small-cell lung cancer (SCLC) chemotherapy:: A phase I study of carboplatin (CBDCA) and etoposide (vp-16).
    Fukuda, M
    Oka, M
    Soejima, Y
    Fukuda, M
    Kinoshita, A
    Takatani, H
    Kasai, T
    Kuba, M
    Soda, H
    Kohno, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 670S - 670S
  • [29] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer
    Hirose, Takashi
    Nakashima, Masanao
    Shirai, Takao
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Ohnishi, Tsukasa
    Ohmori, Tohru
    Adachi, Mitsuru
    LUNG CANCER, 2011, 73 (03) : 345 - 350
  • [30] Multicentre phase II study of carboplatin (AUC 5) and vinorelbine in small cell lung cancer (SCLC)
    Dunlop, DJ
    O'Brien, ME
    Lee, SM
    Hill, S
    Thatcher, N
    BRITISH JOURNAL OF CANCER, 2000, 83 : 42 - 42
12345